Vitamin e intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis

British Journal of Nutrition

Volumn 113, Issue 7, 2015, Pages 1096-1101

  Woestenenk, Janna W ^a   Broos, Nancy ^a   Stellato, Rebecca K ^a   Arets, Hubertus G M ^a   Van Der Ent, Cornelis K ^a   Houwen, Roderick H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coefficient of fat absorption; Cystic fibrosis; IgG; Vitamin E; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CHILD; COEFFICIENT OF FAT ABSORPTION; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GROUPS BY AGE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; YOUNG ADULT; ADOLESCENT DEVELOPMENT; ADVERSE EFFECTS; BLOOD; CHILD DEVELOPMENT; CHILD NUTRITION; COHORT ANALYSIS; DIET; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; INTESTINE ABSORPTION; LONGITUDINAL STUDY; METABOLISM; NETHERLANDS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RESPIRATORY SYSTEM; VITAMIN E DEFICIENCY;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ALPHA-TOCOPHEROL; CHILD; CHILD DEVELOPMENT; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; DIET; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; INTESTINAL ABSORPTION; LONGITUDINAL STUDIES; MALE; NETHERLANDS; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 84928648217     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515000215     Document Type: Article

References (23)

1. Borowitz D, Baker RD & Stallings V (2002) Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 35, 246-259.
2. Sinaasappel M, Stern M, Littlewood J, et al. (2002) Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 1, 51-75.
3. O'Sullivan BP & Freedman SD (2009) Cystic fibrosis. Lancet 373, 1891-1904.
4. Brown RK & Kelly FJ (1994) Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 49, 738-742.
5. Hakim F, Kerem E, Rivlin J, et al. (2007) Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 45, 347-353.
6. Lagrange-Puget M, Durieu I, Ecochard R, et al. (2004) Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol 38, 43-49.
7. Range SP, Dunster C, Knox AJ, et al. (1999) Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. Eur Respir J 13, 560-564.
8. Levy H, Kalish LA, Huntington I, et al. (2007) Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 42, 256-262.
9. van de Weert-van Leeuwen PB, Slieker MG, Hulzebos HJ, et al. (2012) Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur Respir J 39, 893-898.
10. Huang SH, Schall JI, Zemel BS, et al. (2006) Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr 148, 556-559.
11. Wood LG, Fitzgerald DA, Lee AK, et al. (2003) Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 77, 150-159.
12. Centers for Disease Control and Prevention (2012) NHANES 2005-2006 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population, 2nd ed. Hyattsville, MD: Centers for Disease Control and Prevention.
13. Koopman M, Zanen P, Kruitwagen CL, et al. (2011) Reference values for paediatric pulmonary function testing: The Utrecht dataset. Respir Med 105, 15-23.
14. Miller ERIII, Pastor-Barriuso R, Dalal D, et al. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142, 37-46.
15. Sesso HD, Buring JE, Christen WG, et al. (2008) Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300, 2123-2133.
16. Dorlochter L, Aksnes L & Fluge G (2002) Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway. Eur J Nutr 41, 148-152.
17. Bjelakovic G, Nikolova D, Gluud LL, et al. (2012) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 3, CD007176.
18. Azzi A (2007) Molecular mechanism of alpha-tocopherol action. Free Radic Biol Med 43, 16-21.
19. Farrell PM, Levine SL, Murphy MD, et al. (1978) Plasma tocopherol levels and tocopherol-lipid relationships in a normal population of children as compared to healthy adults. Am J Clin Nutr 31, 1720-1726.
20. Cynamon HA, Milov DE, Valenstein E, et al. (1988) Effect of vitamin E deficiency on neurologic function in patients with cystic fibrosis. J Pediatr 113, 637-640.
21. Feranchak AP, Sontag MK, Wagener JS, et al. (1999) Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 135, 601-610.
22. Sokol RJ, Reardon MC, Accurso FJ, et al. (1989) Fat-solublevitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 50, 1064-1071.
23. Maqbool A & Stallings VA (2008) Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 14, 574-581.